Inmune Bio, Inc. (INMB): Shares Outstanding

Annual figures by period end, from SEC filings.

26.59M
As of 2025-12-31
27.65M
As of 2026-06-30
+14.0%
3-year compound annual growth
+14.5%
5-year compound annual growth
2017-12-31: 8.32M2018-12-31: 8.72M2019-12-31: 10.77M2020-12-31: 13.48M2021-12-31: 17.84M2022-12-31: 17.95M2023-12-31: 17.95M2024-12-31: 22.28M2025-12-31: 26.59M26.59M
2017-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3126.59M+19.3%2026-03-30, Balance as of period end
2024-12-3122.28M+24.1%2026-03-30, Balance as of period end
2023-12-3117.95M0.0%2025-03-27, Balance as of period end
2022-12-3117.95M+0.6%2024-03-28, Balance as of period end
2021-12-3117.84M+32.4%2023-03-02, Balance as of period end
2020-12-3113.48M+25.2%2022-03-03, Balance as of period end
2019-12-3110.77M+23.5%2021-03-04, Balance as of period end
2018-12-318.72M+4.8%2020-03-11, Balance as of period end
2017-12-318.32Mn/a2019-03-29, Balance as of period end